Industry Perspectives
| 8 min read
Two review papers consolidate 30 years of research.
| 6 min read
Evotec announces strong progress in strategic protein degradation partnership with Bristol Myers Squibb
| 1 min read
A unique cell-penetrating peptide nanoparticle delivers RNA directly to tumor cells, avoiding a decade-old problem with therapeutic RNA delivery.
| 1 min read
A new kid on the block flips the script using a systems biology-inspired tissue-specific approach against metastatic cancer that normalizes the tumor microenvironment.
